Mednax Inc (MD)
NYSE:MD
Mednax Stock Analysis & Ratings
MD Stock Chart & Stats
Day’s Range$17.55 - $18.5
52-Week Range$17.17 - $35.67
Previous Close$17.69
Volume2.27M
Average Volume (3M)527.92K
Market Cap$1.60B
P/E Ratio17.2
Beta2.05
Next EarningsAug 04, 2022
EPS Forecast$0.48
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$22.29
Smart Score5
EPS (TTM)1.07
Mednax News
P/E Ratio Range
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MD FAQ
What was Mednax’s price range in the past 12 months?
Mednax lowest stock price was $17.17 and its highest was $35.67 in the past 12 months.
What is Mednax’s market cap?
Mednax’s market cap is $1.60B.
What is Mednax’s price target?
The average price target for Mednax is $22.29. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $30.00 ,the lowest forecast is $16.00. The average price target represents 21.27% Increase from the current price of $18.38.
The highest analyst price target is $30.00 ,the lowest forecast is $16.00. The average price target represents 21.27% Increase from the current price of $18.38.
What do analysts say about Mednax?
Mednax’s analyst rating consensus is a ‘Hold. This is based on the ratings of 7 Wall Streets Analysts.
When is Mednax’s upcoming earnings report date?
Mednax’s upcoming earnings report date is Aug 04, 2022 which is in 80 days.
How were Mednax’s earnings last quarter?
Mednax released its earnings results on Apr 28, 2022. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.272 by $0.058.
Is Mednax overvalued?
According to Wall Street analysts Mednax’s price is currently Undervalued.
Does Mednax pay dividends?
Mednax does not currently pay dividends.
What is Mednax’s EPS estimate?
Mednax’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mednax have?
Mednax has 87,260,000 shares outstanding.
What happened to Mednax’s price movement after its last earnings report?
Mednax reported an EPS of $0.33 in its last earnings report, beating expectations of $0.272. Following the earnings report the stock price went down -8.935%.
Which hedge fund is a major shareholder of Mednax?
Among the largest hedge funds holding Mednax’s share is Brandes Investment Partners LP. It holds Mednax’s shares valued at 3M.
---
Mednax Stock Analysis
Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Price Target
$22.29
Hold▲(21.27% Upside)
Analyst Forecast
Hold
Average Price Target: $22.29
Blogger Sentiment
Bullish
MD Sentiment 100% Sector Average 71%
Hedge Fund Holdings
▼ Decreased
By 30.2K Shares Last Quarter.
Insider Transactions
N/A
Currently Not Enough Data Available
Retail Investors
N/A
Currently Not Enough Data Available
News Sentiment
Neutral
Bullish 100% Bearish 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.44%
12-Months-Change
Fundamentals
Return on Equity
9.94%
Trailing 12-Months
Asset Growth
-5.75%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Mednax Inc
MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company's solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting. MEDNAX was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.
---
---